Correctly diagnosing hypertension in children is crucial for identifying other underlying conditions and allowing for earlier treatment and better outcomes, explained Tammy Brady, MD, PhD, medical director of the Pediatric Hypertension Program and associate professor of pediatrics at Johns Hopkins University.
Correctly diagnosing hypertension in children is crucial for identifying other underlying conditions and allowing for earlier treatment and better outcomes, explained Tammy Brady, MD, PhD, medical director of the Pediatric Hypertension Program and associate professor of pediatrics at Johns Hopkins University.
Transcript
What are the dangers of missed or incorrect diagnosis of hypertension in children?
Hypertension in childhood is often the result of another condition, frequently related to the kidney but can also be related to rheumatologic diseases, endocrine disorders, and so elevated blood pressure is often the first sort of sign that there’s something else going on. And so by missing elevated blood pressure, underdiagnosing this, you’re missing an opportunity to diagnose and identify another condition, and many of those conditions, the earlier that they’re identified and treated really can be the most impactful in terms of the outcomes.
As an example, in pediatric nephrology, say a child who has focal segmental glomerulosclerosis, he or she may feel fine and have no outward signs that anything is going on with their kidney; however, they may have an elevated blood pressure that’s identified at their primary care doctor for whatever reason, and that elevated blood pressure will prompt a work-up that will ultimately identify proteinuria and elevated creatinine, and that will allow for earlier intervention and earlier treatment, which can delay kidney disease progression and potentially even prevent end-stage renal disease from developing.
In terms of overdiagnosis, certainly with overdiagnosis comes the risk of having overutilization, overtesting, potentially inducing anxiety in the child or the family, but I actually in my experience find this to be less of a problem. Certainly this is a problem if you rely on the first blood pressure that’s obtained in a clinic setting, but the American Academy of Pediatrics has really tried to emphasize the need for repeated measurements in a clinic setting over repeated visits and additionally the use of ambulatory blood pressure monitoring prior to even giving a child a diagnosis of hypertension or even initiating a work-up. And so hopefully as these guidelines get more broadly implemented, overdiagnosis will be less of a problem.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More